Triple-Therapy Trials for Chronic Obstructive Pulmonary Disease: Methodological Considerations in the Mortality Effect
Gespeichert in:
| Veröffentlicht in: | American journal of respiratory and critical care medicine 2021-04, Vol.203 (7), p.925-926 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 926 |
|---|---|
| container_issue | 7 |
| container_start_page | 925 |
| container_title | American journal of respiratory and critical care medicine |
| container_volume | 203 |
| creator | López-Campos, José Luis Fernández-Villar, Alberto Ruano-Ravina, Alberto |
| description | |
| doi_str_mv | 10.1164/rccm.202012-4386LE |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8017588</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2478598709</sourcerecordid><originalsourceid>FETCH-LOGICAL-c402t-894b844b9a13c8ba0cf44da33dae0cbbad8da5c573ec03b328a98e3d22aa2e8e3</originalsourceid><addsrcrecordid>eNpVkU9v1DAQxS1ERUvhC3BAPnJJ8b80DgcktCxtpa3awyJxsybOpDFy4sV2Vtpvj6stFT35WfPmzYx-hHzg7ILzS_U5WjtdCCYYF5WS-nKzfkXOeC3rSrUNe100a2SlVPvrlLxN6TcrRs3ZG3IqpVKq5uKM7LfR7TxW2xEj7A60fMEnOoRIV2MMs7P0rks5Lja7PdL7xU9hhnig311CSPiF3mIeQx98eHAWPF2FObm-hGVXFHUzzSPS2xAzeJcPdD0MaPM7cjKUOfj-6T0nP3-st6vranN3dbP6tqmsYiJXulWdVqprgUurO2B2UKoHKXtAZrsOet1DbetGomWyk0JDq1H2QgAILOqcfD3m7pZuwt7inCN4s4tuKkeYAM68rMxuNA9hbzTjTa11Cfj0FBDDnwVTNpNLFr2HGcOSjFCNrlvdsLZYxdFqY0gp4vA8hjPzCMw8AjNHYOYIrDR9_H_B55Z_hORfWTaXNQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2478598709</pqid></control><display><type>article</type><title>Triple-Therapy Trials for Chronic Obstructive Pulmonary Disease: Methodological Considerations in the Mortality Effect</title><source>MEDLINE</source><source>American Thoracic Society (ATS) Journals Online</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>López-Campos, José Luis ; Fernández-Villar, Alberto ; Ruano-Ravina, Alberto</creator><creatorcontrib>López-Campos, José Luis ; Fernández-Villar, Alberto ; Ruano-Ravina, Alberto</creatorcontrib><identifier>ISSN: 1073-449X</identifier><identifier>ISSN: 1535-4970</identifier><identifier>EISSN: 1535-4970</identifier><identifier>DOI: 10.1164/rccm.202012-4386LE</identifier><identifier>PMID: 33444512</identifier><language>eng</language><publisher>United States: American Thoracic Society</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Bronchodilator Agents - therapeutic use ; Budesonide - therapeutic use ; Correspondence ; Drug Combinations ; Female ; Formoterol Fumarate - therapeutic use ; Glycopyrrolate - therapeutic use ; Humans ; Male ; Middle Aged ; Pulmonary Disease, Chronic Obstructive - drug therapy ; Pulmonary Disease, Chronic Obstructive - mortality ; Treatment Outcome</subject><ispartof>American journal of respiratory and critical care medicine, 2021-04, Vol.203 (7), p.925-926</ispartof><rights>Copyright © 2021 by the American Thoracic Society 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c402t-894b844b9a13c8ba0cf44da33dae0cbbad8da5c573ec03b328a98e3d22aa2e8e3</citedby><cites>FETCH-LOGICAL-c402t-894b844b9a13c8ba0cf44da33dae0cbbad8da5c573ec03b328a98e3d22aa2e8e3</cites><orcidid>0000-0001-9927-7453 ; 0000-0003-1703-1367 ; 0000-0001-7407-5249</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,4011,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33444512$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>López-Campos, José Luis</creatorcontrib><creatorcontrib>Fernández-Villar, Alberto</creatorcontrib><creatorcontrib>Ruano-Ravina, Alberto</creatorcontrib><title>Triple-Therapy Trials for Chronic Obstructive Pulmonary Disease: Methodological Considerations in the Mortality Effect</title><title>American journal of respiratory and critical care medicine</title><addtitle>Am J Respir Crit Care Med</addtitle><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Bronchodilator Agents - therapeutic use</subject><subject>Budesonide - therapeutic use</subject><subject>Correspondence</subject><subject>Drug Combinations</subject><subject>Female</subject><subject>Formoterol Fumarate - therapeutic use</subject><subject>Glycopyrrolate - therapeutic use</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Pulmonary Disease, Chronic Obstructive - drug therapy</subject><subject>Pulmonary Disease, Chronic Obstructive - mortality</subject><subject>Treatment Outcome</subject><issn>1073-449X</issn><issn>1535-4970</issn><issn>1535-4970</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkU9v1DAQxS1ERUvhC3BAPnJJ8b80DgcktCxtpa3awyJxsybOpDFy4sV2Vtpvj6stFT35WfPmzYx-hHzg7ILzS_U5WjtdCCYYF5WS-nKzfkXOeC3rSrUNe100a2SlVPvrlLxN6TcrRs3ZG3IqpVKq5uKM7LfR7TxW2xEj7A60fMEnOoRIV2MMs7P0rks5Lja7PdL7xU9hhnig311CSPiF3mIeQx98eHAWPF2FObm-hGVXFHUzzSPS2xAzeJcPdD0MaPM7cjKUOfj-6T0nP3-st6vranN3dbP6tqmsYiJXulWdVqprgUurO2B2UKoHKXtAZrsOet1DbetGomWyk0JDq1H2QgAILOqcfD3m7pZuwt7inCN4s4tuKkeYAM68rMxuNA9hbzTjTa11Cfj0FBDDnwVTNpNLFr2HGcOSjFCNrlvdsLZYxdFqY0gp4vA8hjPzCMw8AjNHYOYIrDR9_H_B55Z_hORfWTaXNQ</recordid><startdate>20210401</startdate><enddate>20210401</enddate><creator>López-Campos, José Luis</creator><creator>Fernández-Villar, Alberto</creator><creator>Ruano-Ravina, Alberto</creator><general>American Thoracic Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-9927-7453</orcidid><orcidid>https://orcid.org/0000-0003-1703-1367</orcidid><orcidid>https://orcid.org/0000-0001-7407-5249</orcidid></search><sort><creationdate>20210401</creationdate><title>Triple-Therapy Trials for Chronic Obstructive Pulmonary Disease: Methodological Considerations in the Mortality Effect</title><author>López-Campos, José Luis ; Fernández-Villar, Alberto ; Ruano-Ravina, Alberto</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c402t-894b844b9a13c8ba0cf44da33dae0cbbad8da5c573ec03b328a98e3d22aa2e8e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Bronchodilator Agents - therapeutic use</topic><topic>Budesonide - therapeutic use</topic><topic>Correspondence</topic><topic>Drug Combinations</topic><topic>Female</topic><topic>Formoterol Fumarate - therapeutic use</topic><topic>Glycopyrrolate - therapeutic use</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Pulmonary Disease, Chronic Obstructive - drug therapy</topic><topic>Pulmonary Disease, Chronic Obstructive - mortality</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>López-Campos, José Luis</creatorcontrib><creatorcontrib>Fernández-Villar, Alberto</creatorcontrib><creatorcontrib>Ruano-Ravina, Alberto</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of respiratory and critical care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>López-Campos, José Luis</au><au>Fernández-Villar, Alberto</au><au>Ruano-Ravina, Alberto</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Triple-Therapy Trials for Chronic Obstructive Pulmonary Disease: Methodological Considerations in the Mortality Effect</atitle><jtitle>American journal of respiratory and critical care medicine</jtitle><addtitle>Am J Respir Crit Care Med</addtitle><date>2021-04-01</date><risdate>2021</risdate><volume>203</volume><issue>7</issue><spage>925</spage><epage>926</epage><pages>925-926</pages><issn>1073-449X</issn><issn>1535-4970</issn><eissn>1535-4970</eissn><cop>United States</cop><pub>American Thoracic Society</pub><pmid>33444512</pmid><doi>10.1164/rccm.202012-4386LE</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0001-9927-7453</orcidid><orcidid>https://orcid.org/0000-0003-1703-1367</orcidid><orcidid>https://orcid.org/0000-0001-7407-5249</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1073-449X |
| ispartof | American journal of respiratory and critical care medicine, 2021-04, Vol.203 (7), p.925-926 |
| issn | 1073-449X 1535-4970 1535-4970 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8017588 |
| source | MEDLINE; American Thoracic Society (ATS) Journals Online; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| subjects | Adult Aged Aged, 80 and over Bronchodilator Agents - therapeutic use Budesonide - therapeutic use Correspondence Drug Combinations Female Formoterol Fumarate - therapeutic use Glycopyrrolate - therapeutic use Humans Male Middle Aged Pulmonary Disease, Chronic Obstructive - drug therapy Pulmonary Disease, Chronic Obstructive - mortality Treatment Outcome |
| title | Triple-Therapy Trials for Chronic Obstructive Pulmonary Disease: Methodological Considerations in the Mortality Effect |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T10%3A37%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Triple-Therapy%20Trials%20for%20Chronic%20Obstructive%20Pulmonary%20Disease:%20Methodological%20Considerations%20in%20the%20Mortality%20Effect&rft.jtitle=American%20journal%20of%20respiratory%20and%20critical%20care%20medicine&rft.au=L%C3%B3pez-Campos,%20Jos%C3%A9%20Luis&rft.date=2021-04-01&rft.volume=203&rft.issue=7&rft.spage=925&rft.epage=926&rft.pages=925-926&rft.issn=1073-449X&rft.eissn=1535-4970&rft_id=info:doi/10.1164/rccm.202012-4386LE&rft_dat=%3Cproquest_pubme%3E2478598709%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2478598709&rft_id=info:pmid/33444512&rfr_iscdi=true |